PVAAS: identify variants associated with aberrant splicing from RNA-seq.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25573917.
- Also identified by DOI 10.1093/bioinformatics/btv001 and PMC identifier 4807355.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
RNA-seq has been widely used to study the transcriptome. Comparing to microarray, sequencing-based RNA-seq is able to identify splicing variants and single nucleotide variants in one experiment simultaneously. This provides unique opportunity to detect variants that associated with aberrant splicing. Despite the popularity of RNA-seq, no bioinformatics tool has been developed to leverage this advantage to identify variants associated with aberrant splicing. We have developed PVAAS, a tool to identify single nucleotide variants that associated with aberrant alternative splicing from RNA-seq data. PVAAS works in three steps: (i) identify aberrant splicings; (ii) use user-provided variants or perform variant calling; (iii) assess the significance of association between variants and aberrant splicing events.
Medical subject headings
- Alternative Splicing
- Gene Expression Profiling
- Genetic Variation
- Sequence Analysis, RNA
- Software